Abs 1187 apremilast may have beneficial effects on cardiometabolic measures including reductions in HbA1c in severely obese patients and reductions in weight and dz activity improvements in PsO/ PsA outcomes across all BMI categories. #ACR22 @RheumNow https://t.co/fCdJxz2IDk https://t.co/mLnwKQs539

• Obesity Burden and Effects of Apremilast on Changes in Cardiometabolic Paramete…

Enjoy the post-session adult beverage #ACR22 and #rheumtwitter but, choose wisely as Abs 1206 finds beer consumption was consistently assoc'd w/ higher serum urate levels, whereas sake showed only modest associations in both males and females. @RheumNow https://t.co/ETtU31iTZ0 https://t.co/keG5IN7LbC

• Association Between Different Alcoholic Beverages and Serum Urate Level: A Cros…

Catch our daily recap LIVE at 5pm ET. #ACR22 https://t.co/OpPcGhnWJ1

Dr. @Drbeckyg reminds us that self-reported, RA patient completed joint counts are good for tender and ok for swollen. Check out her videos for teaching joint counts to your patients - all under 8 minutes in total. #ACR22 @RheumNow https://t.co/E2wBsNFS12

Makol @AshimaMakol et al. Digital ischaemia 79% SSc patients. Higher risk - digital occlusive arterial disease on laser doppler flowmetry Macrovascular disease on US, ILD, calcinosis, pericardial effusion. @RheumNow #ACR22 Abstr#1518 https://t.co/DJTtCVD0Oe https://t.co/9i4Vivir8q

• Prevalence, Risk Factors and Treatment Patterns of Digital Ischemic Complicatio…

Chen et al. Tofacitinib in new-onset PMR. Tofa (No GC!) vs standard GC. Equally effective! @RheumNow #ACR22 Abstr#1107 #ACRbest https://t.co/w3WJ8YZsyz https://t.co/qmt1RUAAGB

• Efficacy and Safety of Tofacitinib in Patients with Polymyalgia Rheumatica (EAS…

Pike M Abstract 1113. Remibrutinib (LOU064) in Sjögren’s Syndrome: Safety and Efficacy Results from a 24‑Week Placebo-controlled Proof-of-Concept Study #ACRBest #ACR22 @RheumNow

"Telemedicine is not inferior to F2F visits in Rheumatology!" Dr. @RheumNow. While this may be true, it takes patient education and setting expectations about the visit (no driving during appointment!) #ACR22 @KDAO2011

Torgutalp et al. Higher NSAID intake associated reduced spinal progression in AxSpA esp. r-AxSpA. Cox-2 may have greater effect than other NSAIDs. @RheumNow #ACR22 Abstr#1492 https://t.co/bGH6bBo7AD https://t.co/XBFV410Y2p

• Treatment with Non-steroidal Anti-inflammatory Drugs Is Associated with Retarda…

Baker et al, Corevitas registry in 7000+ RA pts Pts w/ moderate pain HR 1.37 Pts w/ severe pain HR 1.42 more likely to switch to diff MOA b/tsDMARD Adjusted for confounders incl DA Time we address pain separately to spare MAOs in a lifelong disease! Abs#1590 #ACR22 @Rheumnow https://t.co/RP8Rb6bp9m

Joerns et al. Baseline IL-17 higher in RD-ILD vs IPF. Low IL-13 assoc shorter progression free survival HR 17.36 @RheumNow #ACR22 Abstr#1109 https://t.co/I8R3SrxNfV https://t.co/he1A3SYDp0

• High Interleukin-13 Level Is Associated with Disease Stability in Interstitial …

Goldman et al. RTX, TCZ in SSc ILD. 129 patients, 87 RTX, 32 TCZ, 10 both. Median changes in %FVC and %DLCO pre-and post-treatment were +0.35% and -0.8% for rituximab and -0.9% and +0.2% for tocilizumab. Majority stable/improved @RheumNow #ACR22 Abstr#1520 https://t.co/ydY5FGEYnQ https://t.co/O9QD7nkjdZ

• Rituximab and Tocilizumab and Their Effect on Lung Disease Progression in Scler…

"Tweeting a conference is hard work!" @rheum_cat is right! Shout out to all of the #rheumtwitter, RN reporters, conference attendees and all of those tweeting from home! #ACR22 @RheumNow

Avouac @AvouacJerome et al. Maintaining complete B cell depletion assoc RTX efficacy in CTD-ILD. % with FVC improvement - 67% vs 50% for B cell depletion 1 year, 89% vs 50% B cell depletion last infusion. @RheumNow #ACR22 Abstr#1527 https://t.co/xr7DHOHci2 https://t.co/2n95PgzLxN

• Maintained Complete B Cell Depletion Is Associated with Rituximab Efficacy in C…